Recent studies have shown the upregulation of TM4SF1-AS1 and its oncogenicity in several types of cancer, including GC, hepatocellular carcinoma, and lung cancer, but the underlying molecular mechanism is not fully understood [30–32]. This evidence concerns the gene TM4SF1 and lung carcinoma.